{
  "[1]": "FDA label for warfarin: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/009218s109lbl.pdf",
  "[2]": "FDA label for ibuprofen: https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/017463s117lbl.pdf",
  "[3]": "Best clinical practice/expert consensus.",
  "[4]": "Mart\u00ednez-Mir I, et al. Nonsteroidal anti-inflammatory drugs and atrial fibrillation. Drug Saf. 2014;37(7):535-542. [PMID:24326054]",
  "[5]": "UpToDate: NSAIDs and risk of arrhythmia, 2023.",
  "[6]": "UpToDate: NSAIDs: Adverse effects on the kidney.",
  "[7]": "Garc\u00eda Rodr\u00edguez LA, et al. Risk of upper gastrointestinal complications among users of traditional NSAIDs and COX 2 inhibitors in the general population. Gastroenterology. 2004;127(5):1322-1330. [PMID:15229996]",
  "[8]": "Whelton A. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med. 1999;106(5B):13S-24S. [PMID:10390106]",
  "[9]": "Lexicomp Drug Allergy Checker. No cross-reactivity between sulfa drugs and NSAIDs/ACE inhibitors.",
  "[10]": "American College of Obstetricians and Gynecologists (ACOG). Hypertension in pregnancy. Practice Bulletin No. 203.",
  "[11]": "FDA label for lisinopril: https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019690s043lbl.pdf",
  "[12]": "UpToDate: Use of antihypertensive drugs in pregnancy and lactation.",
  "[13]": "Hale TW. Medications and Mothers' Milk. Ibuprofen considered safe during lactation.",
  "[14]": "FDA label for metformin: https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021202s027lbl.pdf",
  "[15]": "FDA label for naproxen: https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/017581s098lbl.pdf",
  "[16]": "Lexicomp: Drug Allergy and Cross-Reactivity Table.",
  "[17]": "American Diabetes Association. Standards of Medical Care in Diabetes-2023.",
  "[18]": "Bhala N, et al. Vascular and upper gastrointestinal effects of NSAIDs: meta-analyses of individual participant data from randomized trials. Lancet. 2013;382(9894):769-779. [PMID:23726390]",
  "[19]": "FDA label for amlodipine: https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019787s046lbl.pdf",
  "[20]": "UpToDate: Calcium channel blockers in hypertension.",
  "[21]": "FDA label for acetaminophen: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204767s020lbl.pdf",
  "[22]": "FDA label for aspirin: https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/009768s037lbl.pdf",
  "[23]": "American Academy of Pediatrics. The management of Reye syndrome. Pediatrics. 1982;69(6):724-729.",
  "[24]": "Centers for Disease Control and Prevention (CDC): 'Reye's syndrome - Public Health Statement.'",
  "[25]": "Micromedex Drug Interactions Checker.",
  "[26]": "Best clinical practice/expert consensus (reiterated as general clinical guidance).",
  "[27]": "American Heart Association. Cocaine and acute cardiovascular complications. Circulation. 2007;115(13):1760-1767. [PMID:17389266]",
  "[28]": "UpToDate: Cocaine: Acute intoxication and management.",
  "[29]": "FDA Safety Communication: Benzocaine and Risk of Methemoglobinemia.",
  "[30]": "Guay J. Methemoglobinemia related to local anesthetics: a summary of 242 episodes. Anesth Analg. 2009;108(3):837-845. [PMID:19224782]",
  "[31]": "American Dental Association (ADA): Oral care in elderly patients.",
  "[32]": "FDA label for clopidogrel: https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020839s062lbl.pdf",
  "[33]": "FDA label for enalapril: https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019690s043lbl.pdf",
  "[34]": "FDA label for furosemide: https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/016426s073lbl.pdf",
  "[35]": "FDA label for atorvastatin: https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020702s045lbl.pdf",
  "[36]": "FDA Drug Interactions Table: Atorvastatin/Amlodipine.",
  "[37]": "FDA label for methotrexate: https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/009321s054lbl.pdf",
  "[38]": "UpToDate: Methotrexate drug interactions.",
  "[39]": "FDA label for prednisone: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020457s017lbl.pdf",
  "[40]": "UpToDate: Glucocorticoid adverse effects.",
  "[41]": "ACR guideline: Reproductive health and rheumatic diseases. Arthritis Rheumatol. 2020.",
  "[42]": "UpToDate: Folic acid supplementation in rheumatologic disease and pregnancy.",
  "[43]": "FDA label for digoxin: https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020405s017lbl.pdf",
  "[44]": "FDA label for spironolactone: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/010151s048lbl.pdf",
  "[45]": "UpToDate: Drug interactions with potassium-sparing diuretics and ACE inhibitors.",
  "[46]": "FDA label for amiodarone: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018972s046lbl.pdf",
  "[47]": "FDA label for clarithromycin: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/050662s049lbl.pdf",
  "[48]": "UpToDate: Warfarin drug interactions.",
  "[49]": "FDA label for simvastatin: https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020702s045lbl.pdf",
  "[50]": "FDA label for metoprolol: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019692s034lbl.pdf",
  "[51]": "UpToDate: Drug interactions with statins.",
  "[52]": "UpToDate: Macrolide antibiotic drug interactions."
}